To enjoy additional benefits
CONNECT WITH US
March 20, 2023 05:26 am | Updated 08:45 am IST - NEW DELHI
The COVID-19 National Task Force of the Ministry of Health and Family Welfare on Sunday issued revised clinical guidelines for the management of adult COVID-19 patients.
As per the new guidelines, convalescent plasma therapy and drugs, including lopinavir-ritonavir, molnupiravir, favipiravir, azithromycin and doxycycline, are not to be used for treatment.
“Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of co-infection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease,” the revised guidelines said.
Physical distancing, indoor mask use, hand hygiene, symptomatic management (hydration, anti-pyretics, antitussive), monitoring temperature and oxygen saturation (with pulse oximeters) is vital, the task force says, while adding that it is important to stay in contact with treating physician.
Patients are advised to seek immediate medical attention if there is difficulty breathing, high-grade fever/ severe cough, particularly if lasting for more than five days.
BACK TO TOP
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.